Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Advanced Orthomolecular Research Drives the Conversation Around Healthy Aging and Weight Management with the Launch of benaGenetm


The world's first stable, bioactive and natural dietary supplement that mimics caloric restriction and maximizes the Krebs' Cycle

CALGARY, Alberta, May 24, 2019 /CNW/ -- Leading Canadian supplement formulator, Advanced Orthomolecular Research (AOR), is driving the conversation around healthy aging with their revolutionary benaGenetm supplement. Studied for over 75 years, the benefits of caloric restriction (CR) are well known, with findings1 suggesting a correlation between low-calorie diets, cell vitality, and healthy aging. Recognizing these benefits, AOR's team of scientists created benaGenetm, a first-of-its kind, once-a-day supplement that mimics a low-calorie diet and helps to slow the creation and storage of fat, while supporting the stimulation of over 350 genes known for their anti-aging properties.

Advanced Orthomolecular Research (AOR) Logo (PRNewsfoto/Advanced Orthomolecular Researc)

"Remaining youthful has been the primal desire of humans for some time and has led to the production of an overwhelming number of 'anti-aging' products," said Randall Heilik, RHN, product manager at AOR. "As leaders within the space, we wanted to create a product that would harness the noted biological benefits of caloric restriction, including vitality and cellular heath, without requiring the actual physical caloric limitation."

Formulated with a stabilized form of oxaloacetate acid, a substance that assists in energy generation without the need to increase daily calorie intake, benaGenetm promotes genes that favor youthful cells, is thought to balance blood sugar, and provides a level of environmental protection for mitochondrial and cellular DNA.

benaGenetm represents the world's first stable, bioactive and natural intermediate compound for the Krebs' Cycle, the vital sequence of reactions by which cells generate energy during aerobic respiration. Rolling extensive research, five clinical trials and ten patents into one package, benaGenetm works to increase the conversion of NADH to its oxidized form, NAD. A niacin-derived coenzyme and present in all living cells, NAD is critical for the body's production of ATP and increases cellular energy while activating beneficial genes as related to energy production. By amplifying this process, benaGenetm helps to slow the creation and storage of fat, which promotes vitality and healthy aging.

benaGenetm can be purchased through the AOR Website, retailing at CA $58.95 for 30 capsules. For more information on AOR, please visit https://aor.ca/

ABOUT AOR:
Advanced Orthomolecular Research (AOR), a Canadian-based company with headquarters in Calgary, Alberta, has an established reputation in Canada as the most advanced dietary supplement formulator in the country and likely, the world. AOR believes that truth and transparency are the most important values for any organization to uphold. It is through ethical discipline and evidenced-based science that they lead and advance the natural health industry. AOR seeks to catalyze change, challenge conventions through continuous innovations, and exists to create safe, effective, and therapeutic solutions.

1 "Oxaloacetic Acid Supplementation as a Mimic of Calorie Restriction," 2009. Terra Biological LLC, San Diego, CA 92130, USA

SOURCE Advanced Orthomolecular Research (AOR)


These press releases may also interest you

at 11:16
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...

at 11:15
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...

at 11:10
Through its 2030 Strategic Plan, NJII plans to double the size of the organization and to exceed $70M revenue as it rolls out various new initiatives focused on accelerating technology translation, spurring innovation and upskilling workers. As...

at 11:09
ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint's commercial growth and success over...

at 11:05
With a goal to better inform health care workers about weapons of mass destruction, the Emergency Nurses Association and FBI recently partnered to launch the Bureau's "ABCs on WMDs" podcast series on the association's website....

at 11:00
Emperion is proud to announce the appointment of Matt Padden as the newest addition to its leadership team. With a proven track record of driving sales growth and cultivating strong client relationships, Padden brings a wealth of experience and...



News published on and distributed by: